Buy & Sell Hewlett Packard Enterprise Co (HPE) – Hewlett Packard Enterprise Co Price Today
Aura AI Summary
Key Stats
- $63.83BMarket Cap
- TechnologySector
- -18.96%3M Drawdown
- $79.78BEnterprise Value
- 1.18%Dividend Yield
- 85% Buy | 15% SellTrading Activity
- 30 daysTypical Hold Time
Hewlett Packard Enterprise Co (HPE) is currently valued at a market capitalization of $63.83B, with an enterprise value of $79.78B. Over the past 52 weeks, Hewlett Packard Enterprise Co has traded between a low of $17.78 and a high of $56.14, highlighting its annual price range. Over the past three months, Hewlett Packard Enterprise Co has recorded a drawdown of -18.96%, reflecting recent price volatility. Hewlett Packard Enterprise Co offers a dividend yield of 1.18%, with the most recent dividend of $0.14 paid on 16 Jun 26. On average, investors hold Hewlett Packard Enterprise Co for approximately 30 days, indicating typical investor behavior on the platform.
About Hewlett Packard Enterprise Co
Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment.
Most Recent News
Cell and gene therapy CDMO market set to grow at 24% CAGR, reaching $57.1B by 2034.
The cell and gene therapy contract development and manufacturing organization (CDMO) market is projected to grow at a compound annual growth rate (CAGR) of approximately 24% from 2026 to 2034, reaching a market size of $57.1 billion by 2034. Growth i...

Over 100 drugs in clinical trials aim to transform age-related macular degeneration treatment by 2026
DelveInsight's 2026 report reveals more than 100 drugs in development for age-related macular degeneration (AMD), involving over 90 companies globally. These therapies include novel mechanisms like gene therapy, mitochondrial stabilization, and VEGF ...

Polymeric biomaterials market to hit $267B by 2034, driven by regenerative medicine and healthcare growth.
The global polymeric biomaterials market, valued at $69.55 billion in 2024, is projected to grow at a CAGR of 15.86% to reach $267.25 billion by 2034. Growth is fueled by increasing demand in regenerative medicine, orthopedics, and wound care, with A...
